
|Articles|October 2, 2021
Using ML, AI and RWD to Infer HCP Specialties
Author(s)IPM.ai
Pharmaceutical sales operations teams often rely on outdated or inaccurate data when prioritizing HCP targets, limiting promotional effectiveness. By applying artificial intelligence and machine learning to real world data, pharmaceutical companies can more effectively target physicians hiding in plain sight and PCPs behaving like specialists.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Agentic AI and the Future of Commercial Excellence in Life Sciences
3
FDA Expands Approval for Arexvy for Adult Patients Aged 18-49
4
Americans Cutback on Expenses to Cover Healthcare Costs: Report
5